Associate Professor Adam Nelson

• Biography/ Background

   

  Adam Nelson MBBS MBA/MPH PhD FRACP is an early career academic cardiologist with interests in preventive cardiology, personalized medicine and implementation science. 

  After completing medical school at the University of Adelaide he then completed his FRACP at the Royal Adelaide Hospital. Adam completed a BMedSc honours degree and a PhD evaluating vascular function and risk assessment. He then embarked on a combined MBA and MPH through Laureate Universities with major subjects in epidemiology, implementation science and clinical trial methods undertaken at Duke University while pursuing a 2 year post-doctoral appointment at the Duke Clinical Research Institute.

  Adam is chair or lead investigator on multiple state and national clinical trials evaluating system-based approaches to improve quality of care among patients with established atherosclerotic cardiovascular disease including GOAL-ASIA which will recruit 2000 patients across 8 countries and 40 sites. CI Nelson was the highest ranked candidate for a National Heart Foundation post-doctoral fellowship in 2021, is CI on two MRFF and NHMRC grants and has generated >$AU8million in project funding.

   

• Qualifications

  2018-21 Master of Public Health, Master of Business Administration | MPH / MBA Torrens University; subjects at Duke University; epidemiology, clinical trial methods

  2013-18 Doctorate of Philosophy | PhD | Discipline of Medicine, Faculty of Health Sciences, University of Adelaide

  2004-10 Bachelor of Medicine, Bachelor of Surgery | MBBS | Adelaide Medical School, University of Adelaide

  2007 Honours Bachelor of Medical Science | HBMedSc | Discipline of Medicine, Faculty of Health Sciences, University of Adelaide

• Awards & Achievements

  Academic

  2021 Winner, Shirley E Freeman Award for most innovative Heart Foundation project.

  2020 Finalist, Robert Harrington Award for Research Excellence, Duke University

  2018 Torrens ‘Health Industry’ Scholarship to study MPH/MBA

  2011 Nominee, Royal Adelaide Hospital candidate for SAIMET ‘Junior Doctor of the Year’

  2011 Mace Bearer, Faculty of Health Sciences, Graduation Ceremony

  2010 Australian Medical Association (SA) Medal, for excellence during medical school

   

  Teaching

  2015-16 Intern Teaching Award, Royal Adelaide Hospital, Best Registrar Teacher

  2015 Mark Jolly Fellowship Award, for service and teaching to Royal Adelaide Hospital

  2011 Professor Derek Frewin AO Citation, for Clinical Teaching Service

  2010 Patron’s Plate, for service to peers, Adelaide Medical Students’ Society

  2010 Honorary Life Membership, for service to the Adelaide Medical Students’ Society

  2005 Judith Ann O’Brien Award, Medical School, service and compassion to peers

  2005 President’s Award for service, Adelaide Medical Students’ Society

• Research Funding

  MRFF CV Health Grant MRFF2008437. AI. 2021-2025. $1,669,300

  AMGEN Investigator-initiated. CI. GOAL ASIA. 2021-2023 $2,850,000

  US FDA EHR Demonstration Project, BAA-19-00123 2019-2023. AI. $US1,388,000

  MRFF CV Grant MRFF1201375. CIF. 2020-2022. $1,416,095

  ACC NCDR TVT Project Funding. CIB. 2020-2021 $US65,000

  Clinical Trials Transformation Initiative, Seed Fund. CIB. 2020-2021 $US62,000

• Publications

  1. Nelson AJ, Wegermann ZK, Gallup D, O’Brien S, Kosinksi AS, Thourani VH, Kumbhani D, Kirtane A, Allen J, Carroll JD, Shahian DM, Desai NM, Brindis RG, Peterson ED, Cohen DJ, Vemulapalli S. Comparing volume versus quality thresholds on outcomes and access to Transcatheter Aortic Valve Replacement (TAVR) in the United States: Insights from the TVT Registry. JAMA Cardiology (in press)

  2. Tan S, Sivakumar S, Segelov E, Nicholls SJ, Nelson AJ. Cardiovascular Risk Factor Reporting in Immune Checkpoint Inhibitor Trials. Cancer Epidemiology (in press)

  3. Dawson LP, Nehme E, Nehme Z, Davis E, Bloom J, Cox S, Nelson AJ, Okyere D, Anderson D, Stephenson M, Lefkovits J, Taylor AJ, Nicholls SJ, Cullen L, Kaye D, Smith K, Stub D. Sex differences in epidemiology, care processes and clinical outcomes for patients presenting with acute chest pain. JACC (in press)

  4. Nelson AJ, Nicholls SJ. Managing hypercholesterolaemia. Australian Prescriber (accepted)

  5. Tan S, Pol D, Splatt L, Abrahams T, Mydinb M, Nelson AJ, Nicholls SJ, Brown AJ. Diagnostic Accuracy of Reperfusion Criteria Following Fibrinolysis for ST-Elevation Myocardial Infarction. AsiaIntervention (accepted)

  6. Patel SM, Varshney AS, Stebbins A, Nelson AJ, Parikh PR, Tang GHL, Kaneko T, Vemulapalli S, O’Gara PT, Bhatt DL. Early Recovery of Left Ventricular Systolic Function after Transcatheter Aortic Valve Implantation: Insights from the TVT Registry. Ann Intern Med. (accepted)

  7. Di Giovanni G, Kataoka Y, Bubb K, Nelson AJ, Nicholls SJ. Impact of Lipid Lowering on Coronary Atherosclerosis Moving from the Lumen to the Artery Wall. Atherosclerosis . 2023 Jan 20;367:8-14.

  8. Nanna MG, Nelson AJ, Haynes K, Shambu S, Eapen Z, Cziraky MJ, Calvert SB, Pagidipati NJ, Granger CB. Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease. J Am Geriatr Soc. 2022 Dec 20.

  9. Nicholls SJ, Nelson AJ. CETP Inhibitors: Should We Continue to Pursue this Pathway? Curr Atheroscler Rep. 2022 Dec;24(12):915-923

  10. Nelson AJ, Pagidipati NJ, Kelsey MD, Ardissino M, Aroda VR, Cavender MA, Lopes RD, Al-Khalidi H, Braceras R, Gaynor T, Kaltenbach L, Kirk JK, Lingvay I, Magwire ML, O’Brien EC, Pak J, Pop-Busui R, Richardson CR, Reed MR, Senyucel C, Webb L, McGuire DK, Green JB, Granger CB. COOrdinating CaRDIology CliNics RAndomized Trial of Interventions to Improve OutcomEs (COORDINATE) – Diabetes: Rationale and Design. Am Heart J. 2023 Feb;256:2-12.

  11. Nicholls SJ, Ray KK, Nelson AJ, Kastelein JJP. Can We Revive CETP Inhibitors as an Approach to Preventing Cardiovascular Disease? Curr Opin Lipidol. 2022 Dec 1;33(6):319-325.

  12. Lin RZ, Gallagher C, Tu SJ, Pitman BM, Nelson AJ, Roberts-Thomson RL, Worthley MI, Lau DH, Sanders P, Wong CX. Trends in Acute Myocardial Infarction and Coronary Revascularization Procedures in Australia: A 25-Year Nationwide Analysis from 1993 to 2018. Heart. 2023 Jan 27;109(4):283-288

  13. Carrena O, Young R, Tarrar IH, Nelson AJ, Wojdyla D, Wang TY, Mehta RH. Trends in the Incidence, Risk Factors and Outcomes of Periprocedural Stroke in Patients Undergoing Percutaneous Coronary Interventions. Insights from the ACC NCDR CATHPCI Registry. J Am Coll Cardiol. 2022 Nov 1;80(18):1772-1774.

  14. Nelson AJ, Pagidipati NJ, Granger CB. Reply: High dose statins increase adverse events and do not improve survival. J Am Coll Cardiol. 2022 Oct, 80 (16) e127

  15. Nelson AJ, Inohara T, Rao SV, Kaltenbach LA, Wojdyla D, Wang TY Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry. Am Heart J. 2022 Oct 9;255:117-124.

  16. Nelson AJ, Harrington JL, Kolkailah A, Pagidipati NJ, McGuire DK. Sodium-glucose co-transporter 2 inhibitors: impact on atherosclerosis and ASCVD events. Heart Fail Clin. 2022 Oct;18(4):597-607.

  17. Nelson AJ, Sniderman AD, Ditmarsch M, Dicklin MR, Nicholls SJ, Davidson MH, Kastelein JJP. Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels. Int J Mol Sci. 2022 Aug 20;23(16):9417.

  18. Dowling C, Nelson AJ, Lim RY, Zhang JM, Cheng K, Smith JA, Seneviratne S, Malaiapan Y, Zaman S,  Wong DT. Quantitative Flow Ratio to Predict Long-Term Coronary Artery Bypass Graft Patency in Patients with Left Main Coronary Artery Disease. Int J Cardiovasc Imaging. 2022 Dec;38(12):2811-2818.

  19. Ardissino M, Nelson AJ, Maglietta G, Tagliazucchi GM, Disisto C, Canosi U, Cernetti C, Merlini PA, Berzuini C, Ponte E, Fetiveau R, Buratti S, Paraboschi E, Duga S, Tuttolomondo D, Crocamo A, Barocelli F, Bricoli S, Botti A, Bonura R, Magnani G, Biagi A, Paoli G, Solinas E, Ardissino D. Sex-Based Differences In Long-Term Outcomes After Early-Onset Myocardial Infarction. Front Cardiovasc Med. 2022 Jul 4;9:863811.

  20. Nelson AJ, Haynes K, Shambu S, Eapen Z, Cziraky MJ, Nanna MG, Calvert SB, Pagidipati NJ, Granger CB. Patterns and predictors of high-intensity statin use among patients from the United States with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2022 May 10;79(18):1802-1813. Rank 3/194 | Impact Factor 20.6

  21. Kelsey MD, Nelson AJ, Green JB, Granger CB, Peterson ED, McGuire DK, Pagidipati NJ. Comparison of United States and European Professional Society Guidelines and Consensus Recommendations for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2022 May 10;79(18):1849-1857. Rank 3/194 | Impact Factor 20.6

  22. Bays HE, Kulkarni A, German C, Satish O, Iluyomade A, Dudum R, Thakkar A, Al Rifai M, Mehta A, Thobani A, Al-Saiegh Y, Nelson AJ, Sheth A, Toth P. Ten Things to Know About Ten Cardiovascular Disease Risk Factors – 2022. Am J Prev Cardiol. 2022 Apr 6;10:100342.

  23. Ardissino M, Maglietta G, Tagliazucchi GM, Nelson AJ, Disisto C, Canosi U, Cernetti C, Merlini PA, Berzuini C, Ponte E, Fetiveau R, Buratti S, Paraboschi E, Duga S, Tuttolomondo D, Crocamo A, Barocelli F, Bricoli S, Botti A, Bonura R, Magnani G, Biagi A, Paoli G, Solinas E, Ardissino D. Long-Term Outcomes of Early-Onset Myocardial Infarction With Non-Obstructive Coronary Artery Disease. Int J Cardiol. 2022 May 1;354:7-13

  24. Raman SR, O’Brien EC, Hammill BG, Nelson AJ, Curtis LH, Marsolo K. Evaluating fitness-for-use of electronic health records: reported practices in contemporary pragmatic clinical trials. J Am Med Inform Assoc. 2022 Feb 16:ocac004.

  25. Nelson AJ, O’Brien EC, Kaltenbach LA, Green JB, Lopes RD, Morse CG, Al-Khalidi HR, Aroda VR, Cavender MA, Gaynor T, Kirk JK, Lingvay I, Magwire ML, McGuire DK, Pak J, Pop-Busui R, Richardson CR, Senyucel C, Kelsey MD, Pagidipati NJ, Granger CB. Patterns of Lipid, Blood Pressure and Glucose Lowering Therapy in Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease: Insights from Clinical Research Networks in the United States. JAMA Netw Open. 2022;5(2):e2148030.

  26. Bubb KJ, Nelson, AJ, Nicholls SJ. Residual Cardiovascular Risk: The Future Role of Triglycerides. Exp Reviews Cardiovasc Ther. 2022 Mar;20(3):185-191.

  27. Doll JA, Nelson AJ, Kaltenbach LA, Wojdyla D, Waldo SW, Rao SV, Wang TY. PCI Operator Profiles and Associations with In-hospital Mortality. Circ Cardiovasc Interv. 2022 Jan;15(1):e010909.  Rank 19 | Impact Factor 3.4

  28. Kaneko T, Vemulapalli S, Kohsaka S, Shimamura K, Amanda A, Kumamaru H, Nelson AJ, Kosinski A, Maeda K, Bavaria JE, Saito S, Reardon M, Kuratani T, Popma J, Inohara T, Thourani V, Carroll J, Shimizu H, Takayama M, Leon M, Mack M, Sawa Y. Trends in Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in US and Japan. J Am Heart Assoc. 2022 Mar 4:e023848. Rank 39/194 | Impact Factor 4.6

  29. Nelson AJ, Bubb K, Nicholls SJ. An Update on Emerging Drugs for the Treatment of Hypercholesterolaemia. Expert Opin Emerg Drugs. 2021 Dec;26(4):363-369.

  30. Nathan AS, Manandhar P, Wojdyla D, Nelson AJ, Fiorilli PN, Waldo S, Yeh RW, Rao SV, Fanaroff AC, Groeneveld PW, Wang TY, Giri J. Hospital-Level Percutaneous Coronary Intervention Performance with a Simulated Risk Avoidance Strategy. J Am Coll Cardiol. 2021 Nov, 78 (22) 2213–2217. Rank 3/194 | Impact Factor 20.6

  31. Lopes RD, Higano CS, Slovin SF, Nelson AJ, Bigelow R, Sørensen PS, Melloni C, Goodman SG, Evans CP, Nilsson J, Bhatt DL, Clarke NW, Olesen TK, Doyle-Olsen BT, Kristensen H, Arney L, Roe  MT, Alexander JH. Cardiovascular Safety of Degarelix or Leuprolide in Advanced Prostate Cancer. Circulation. 2021 Oct 19;144(16):1295-1307. Rank 1/194 | Impact Factor 23.6

  32. Tada H, Yeo KK, Li JJ, Tan K, Krittayaphong R, Tan RS, Aylward Pe, Lam CSP, Baek SH, Dalal J, Fong A, Li Y-H, O’Brien RC, Koh SYN, Scherer DJ, Kang V, Nelson AJ, Butters J, Nicholls SJ. Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia Pacific Region. JACC: Asia 2021 Dec, 1 (3) 294–302. Impact Factor 4.7

  33. Khan E, Lambrakis K, Blyth A, Seshadri A, Edmonds MR, Briffa T, Cullen LA, Quinn S, Horsfall M, Morton E, French JK, Papendick P, Nelson AJ, Chew DP. Classification performance of clinical risk scoring in suspected ACS beyond a rule-out troponin profile. Eur Heart J Acute Cardiovasc Care. 2021 Dec 6;10(9):1038-1047.

  34. Valle J, Li Z, Kosinski AS, Nelson AJ, Vemalapalli S, Cleveland J, Fullerton D, Messenger D, Rove J, Bricker R, Bradley S, Masoudi F, Yeh R, Armstrong E, Waldo S, Carroll J. Dissemination of Transcatheter Aortic Valve Replacement in the United States: Insights from the TVT Registry J Am Coll Cardiol. 2021 Aug 24;78(8):794-806. Rank 3/194 | Impact Factor 20.6

  35. Nelson AJ, Pagidipati  NJ, Aroda VA, Cavender MA, Green JB, Lopes RD, Al-Khalidi H, Gaynor T, Kaltenbach L, Kirk J, Lingvay I, Magwire ML, O’Brien EC, Pak J, Pop-Busui R, Richardson CR, Reed M, Senyucel C, Webb L, McGuire DK, Granger CB. Incorporating SGLT2i and GLP-1 RA for Cardiovascular and Kidney Disease Risk Reduction: A Call for Action to the Cardiology Community. Circulation. 2021 Jul 6;144(1):74-84. Rank 1/194 | Impact Factor 23.6

  36. Lambrakis K, Papendick C, French JK, Quinn S, Blyth A, Seshadri A, Edmonds MJR, Chuang A, Khan E, Nelson AJ, Wright D, Horsfall M, Morton E, Karnon J, Briffa T, Cullen LA, Chew DP. The Late Outcomes of a 0/1-Hour High Sensitivity Troponin T Protocol in Suspected Acute Coronary Syndromes (RAPID TnT); A Randomized Clinical Trial. Circulation. 2021 Jul 13;144(2):113-125. Rank 1/194 | Impact Factor 23.6

  37. Nelson AJ, Pagidipati NJ, Granger CG. The SAMSON trial: Using a Placebo to Improve Medication Tolerability. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e13. Rank 20/194 | Impact Factor 6.97

  38. Hejjaji V, Cohen DJ, Carroll JD, Li Z, Manandhar P, Vemulapalli S, Nelson AJ, Malik AO, Mack MJ, Spertus JA, Arnold SV. Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry. Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e007187. Rank 33/194 | Impact Factor 5.1

  39. Nanna MG, Peterson ED, Chiswell K, Overton RA, Nelson AJ, Kong DF, Navar AM. The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease. Atherosclerosis. 2021 Feb 8;321:1-7. Rank 55/194 | Impact Factor 3.92

  40. Nelson AJ, Ardissino M, Haynes K, Shambhu S, Eapen ZJ, McGuire DK, Carnicelli A, Lopes RD, Green JB, O'Brien EC, Pagidipati NJ, Granger CB. Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease. J Am Heart Assoc. 2021 Jan 19;10(2):e016835. Rank 39/194 | Impact Factor 4.6

  41. Nanna MG, Navar AM, Wojdyla D, Nelson AJ, Sullivan AE, Peterson ED. Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events? Am J Cardiol. 2020 Dec 9:S0002-9149(20)31289-3. Rank 93/194 | Impact Factor 2.6 

  42. Nelson AJ, Puri R, Brennan DM, Anderson TJ, Cho L, Ballantyne CM, Kastelein JJP, Koenig W, Kassahun H, Somaratne R, Wasserman SM, Nissen SE, Nicholls SJ. C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV. Am J Prev Cardiol. 2020 Oct 6;3:100091. (New Journal 2020)

  43. Nelson AJ, Nicholls SJ. The fish-oil paradox. Curr Opin Lipidol. 2020 Dec;31(6):356-361. Rank 44/194 | Impact Factor 4.3

  44. Nelson AJ, Puri R, Nissen SE. Statins in a distorted mirror of media. Curr. Atheroscler. Rep Curr Atheroscler Rep. 2020 Jun 18;22(8):37. Rank 38/194 | Impact Factor 4.6

  45. Nicholls SJ, Nelson AJ. Statins for primary prevention in the elderly: The importance of Rigorous Evidence. JAMA. 2020 Jul 7;324(1):45-46. Rank 3/168 | Impact Factor 45.5

  46. Nelson AJ, Navar AM, Mulder H, Wojdyla D, Philip S, Granowitz C, Peterson ED, Pagidipati NJ. Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial). Am J Cardiol. 2020 Oct 1;132:36-43. Rank 93/194 | Impact Factor 2.6

  47. Nanna MG, Chen S, Nelson AJ, Navar AM, Peterson ED. Has the Inclusion Across the Lifespan Policy Affected Representation of Older Adults in Cardiovascular Disease Trials? JAMA Intern. Med. 2020 Sep 8;180(11):1531-3. Rank 7/168 | Impact Factor 18.7

  48. Kivi AR, Sedaghatizadeh N, Cazzolato BS, Zander AC, Roberts-Thomson R, Nelson AJ, Arjomandi M. Fluid structure interaction modelling of aortic valve stenosis: Effects of valve calcification on coronary artery flow and aortic root hemodynamics. Comput Methods Programs Biomed. 2020 Nov;196:105647. Impact Factor 3.6

  49. Montarello NJ, Nelson AJ, Wong DTL, Verjans J, Nicholls SJ, Psaltis PJ. The Role of Intracoronary Imaging in Translational Research. Cardiovasc Diagn Ther. 2020 Oct;10(5):1480-1507. Rank 91 | Impact Factor 2.6

  50. Baumann AAW, Mishra A, Worthley MI, Nelson AJ, Psaltis PJ. Management of multi-vessel coronary artery disease in patients with non-ST-elevation myocardial infarction: A complex path to precision medicine. Ther Adv Chronic Dis. 2020 Jul 1;11:2040622320938527. Impact Factor 1.3

  51. Joynt Maddox K, Bleser WK, Crook HL, Nelson AJ, Hamilton Lopez M, Saunders RS, McClellan MB, Brown N; American Heart Association Value-Based Models Learning Collaborative. Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative's Value-Based Models Learning Collaborative. Circ Cardiovasc Qual Outcomes. 2020 May;13(5):e006483. Rank 33/194 | Impact Factor 5.1

  52. Montarello NL, Roberts-Thomson RL, Montarello NJ, Nelson AJ, Montarello JK, Worthley SG. Two-in-one: Combined transcatheter therapy for hypertrophic cardiomyopathy and aortic stenosis. IHJ Cardiovascular Case Reports (CVCR) 2020 (New Journal 2020)

  53. Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting Vascular Calcification in Chronic Kidney Disease.  JACC Basic Transl Sci. 2020 Apr 27;5(4):398-412. Impact Factor 3.7

  54. Nelson AJ, Nicholls SJ. Translating evidence from clinical trials of omega-3 fatty acids to clinical practice. Future Cardiol. Jul;16(4):343-350. Impact Factor 1.2

  55. Nelson AJ, Patel MR. Ischaemic stroke in heart failure: back to basics? Heart. 2020 Apr;106(8):555-556. Rank 32/194 | Impact Factor 5.2

  56. Nelson AJ, Worthley MI. Reply to "Letter to the Editor: Aortic distensibility and coronary blood flow: does cardiac period play a role?" Am J Physiol Heart Circ Physiol. 2019 Dec 1;317(6):H1389. Impact Factor 3.9

  57. Nelson AJ, Puri R, Nicholls SJ, Dundon BK, Richardson JD, Sidharta SL, Teo KS, Worthley SG, Worthley M. Aortic distensibility is associated with both resting and hyperemic coronary blood flow. Am J Physiol Heart Circ Physiol. 2019 Oct 1;317(4):H811-H819. Impact Factor 3.9

  58. Nelson AJ, Alexander JH. Anticoagulation-Related Major Bleeding in Patients With Atrial Fibrillation: Looking Behind the Curtain. Circulation. 2019 Nov 26;140(22):1802-1804. Rank 1/194 | Impact Factor 23.6

  59. Nelson AJ, Ardissino M, Psaltis PJ. Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers. Ther Adv Chronic Dis. 2019 Nov 1;10:2040622319884819. Impact Factor 1.3

  60. Nelson AJ, Mirzaee S, Nicholls SJ. High-Dose Omega-3 Fatty Acids in Cardiovascular Prevention: Finally Living Up to Their Potential? Am J Cardiovasc Drugs. 2020 Feb;20(1):11-18.

  61. Chew DP, Lambrakis K, Blyth A, Seshadri A, Edmonds MJR, Briffa T, Cullen LA, Quinn S, Karnon J, Chuang A, Nelson AJ, Wright D, Horsfall M, Morton E, French JK, Papendick C. A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT). Circulation. 2019 Nov 5;140(19):1543-1556. Rank 1/194 | Impact Factor 23.6

  62. Jeffs LS, Peh CA, Nelson A, Tan PG, Davey E, Chappell K, Perkins GB, Hurtado PR. IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis. Immunol Res. 2019 Oct;67(4-5):325-336. Impact Factor 2.8

  63. Melloni C, Nelson A. Effect of Androgen Deprivation Therapy on Metabolic Complications and Cardiovascular Risk. J Cardiovasc Transl Res. 2019 Dec 12. Rank 70/194 | Impact Factor 3.3

  64. Nelson AJ, Peterson ED, Pagidipati NJ. Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes. Prog Cardiovasc Dis. 2019 Jul-Aug;62(4):306-314. Rank 19 | Impact Factor 6.8

  65. Granger CB, Nelson AJ, Pagidipati NJ. Risk of Total Events With Icosapent Ethyl: Can we Reduce It? J Am Coll Cardiol. 2019 Jun 11;73(22):2803-2805. Rank 3/194 | Impact Factor 20.6

  66. Nelson AJ, Granger CB. In middle-aged adults, Astro-CHARM was better than a standard risk factor model for predicting 10-year ASCVD risk. Ann Intern Med. 2019 Feb 19;170(4):JC23. Rank 15/168 | Impact Factor 21.3

  67. Nelson AJ, Dundon BK, Worthley SG, Richardson JD, Puri R, Wong DTL, Coates PT, Faull RJ, Worthley MI. End-stage renal failure is associated with impaired coronary microvascular function. Coron Artery Dis. 2019 Nov;30(7):520-527. Rank 165/194 | Impact Factor 1.3

  68. Nelson AJ, Roberts-Thomson RL, Stokes MB, Baumann AA, Nicholls SJ. Pulsatile Torso: Giant Cardiomegaly from Untreated Tricuspid Endocarditis. Postgrad Med J. 2019 Mar;95(1121):174. Rank 76/168 | Impact Factor 1.9

  69. Nicholls SJ, Nelson AJ. Rivaroxaban With or Without Aspirin for the Secondary Prevention of Cardiovascular Disease: Clinical Implications of the COMPASS Trial. Am J Cardiovasc Drugs. 2019 Aug;19(4):343-348. Rank 88/194 | Impact Factor 2.7

  70. Nicholls SJ, Nelson AJ. Do Cholesteryl Ester Transfer Protein Inhibitors Have a Role in the Treatment of Cardiovascular Disease? Am J Cardiovasc Drugs. 2019 Jun;19(3):229-235. Rank 88/194 | Impact Factor 2.7

  71. Nicholls SJ, Nelson AJ. The Time For Lp(a) Based Intervention Has Arrived: Where Will the Light Shine? J. Thorac. Dis. Mar;11(Suppl 3):S433-S436. Impact Factor 2.2

  72. Nicholls SJ, Nelson AJ. HDL and Cardiovascular Disease. Pathology. 2019 Feb;51(2):142-147. Rank 18/78 | Impact Factor 3.0

  73. Scherer DJ, Nelson AJ, O'Brien R, Kostner KM, Hare DL, Colquhoun DM, Barter PJ, Aylward P, Nicholls SJ, Watts GF. Status of PCSK9 monoclonal antibody inhibitors in Australia. Heart Lung Circ. 2019 Oct;28(10):1571-1579. Rank 113/194 | Impact Factor 2.2

  74. Majeed K, Nelson AJ, Psaltis PJ, Worthley MI. Direct-Acting Oral Anticoagulants: less is not always more. Cor et Vasa 2019, 61(4):e436-e438. Impact Factor 0.4

  75. Mahajan R, Nelson AJ, Wong CX, Lau DH, Pathak RK, Twomey D, Teo KS, Selvanayagam J, Hatem SN, Sanders P.  Epicardial fat depots and atrial remodelling in obese patients with atrial fibrillation: evidence for a direct impact.  JACC Clin Electrophysiol. 2018 Dec;4(12):1529-1540. Impact Factor 4.1

  76. Nelson AJ, Montarello NJ, Cosgrove C, Roberts-Thomson RL, Montarello NJ, Delacroix S, Chokka R, Thomas T, Worthley SG. Transcatheter Aortic Valve Implantation (TAVI): A New Standard of Care. Med J Aust. 2018 Aug 6;209(3):136-141. Rank 16/168 | Impact Factor 6.1

  77. Nicholls SJ, Nelson AJ. Monitoring the Response to Statin Therapy: One Scan at a Time. JACC Cardiovasc Imaging. 2018 Oct;11(10):1485-1486. Rank 7/194 | Impact Factor 12.7

  78. Delacroix S, Chokka G, Nelson AJ, Wong, D. T. Sidharta, S. Pederson, SM, Rajwani A, Nimmo J, Teo, KS, Worthley SG.  Effects of Renal Sympathetic Denervation on Myocardial Structure, Function and Perfusion: A Serial CMR Study.  Atherosclerosis. 2018 Mar 10;272:207-215. Rank 55/194 | Impact Factor 3.9

  79. Nelson AJ, Nicholls SJ.  Treating Dyslipidemia in Type 2 Diabetes.  Cardiol Clin. 2018 May;36(2):233-239. Rank 134/194 | Impact Factor 1.8

  80. Nelson AJ, Roberts-Thomson RL, Nicholls SJ.  Mechanisms of Coronary Ischaemia in Women: Are We Any Closer to Deciphering the Code?  Eur. J. Prev. Cardiol 2018 May; 25(7):717-718. Rank 23/194 | Impact Factor 5.8

  81. Nelson AJ, Rochelau SK, Nicholls SJ.  (2017). Managing Dyslipidemia in Type 2 Diabetes. Endocrinol Metab Clin North Am. 2018 Mar;47(1):153-173. Impact Factor 3.8

  82. Papendick C, Blyth A, Seshadri A, Edmonds MJR, Briffa T, Cullen L, Quinn S, Karnon J, Chuang A,  Nelson AJ, Horsfall M, Morton E, Chew DP.  A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: Design of the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T (RAPID-TnT) study. Am Heart J. 2017 Aug;190:25-33. Rank 47/194 | Impact Factor 4.2

  83. Kontos A, Willoughby S, van den Heuvel C, Kennedy D, Martin J, Hodge G, Worthley M, Chin AK, Nelson A, Teo K, Baumert M, Pamula Y, Lushington K.  Ascending aortic blood flow velocity is increased in children with primary snoring/mild sleep-disordered breathing and associated with an increase in CD8 +  T cells expressing TNFα and IFNγ.  Heart Vessels. 2018 May;33(5):537-548. Rank 151/194 | Impact Factor 1.6

  84. Mauro MS, Nelson AJ, Stokes MB.  Troponin Testing in Primary Care.  Aust Fam Physician. 2017 Nov;46(11):823-826. Rank 105/168 | Impact Factor 1.2

  85. De La Croix S, Chokka G, Nelson AJ, Wong, D. T. Sidharta, S. Pederson, SM, Rajwani A, Nimmo J, Teo, KS, Worthley SG. Renal Sympathetic Denervation Increases Renal Blood Volume Per Cardiac Cycle: A Serial MRI Study in Resistant Hypertension.  Int J Nephrol Renovasc Dis.2017 Aug 31;10:243-249. Impact Factor 2.4

  86. Scherer DJ, Nelson AJ, Psaltis PJ, Nicholls SJ. Targeting LDL Cholesterol with PCSK9 Inhibitors. Intern Med J. 2017 Aug;47(8):856-865. Rank 86/168 | Impact Factor 1.7

  87. Roberts-Thomson RL, Nelson AJ, Psaltis PJ, Sundaranajan K.  Therapeutic Paradox : Nimodipine attenuates severe coronary spasm following coronary artery graft surgery in a high risk vasoplegic cancer patient.  Intern Med J. 2017 Feb;47(2):229-231. Rank 86/168 | Impact Factor 1.7

  88. Majeed K, Lucking AJ, Roberts-Thomson RL, Nelson AJ, Montarello JK, Worthley SG.  Transcatheter Aortic Valve Replacement: A Solution for the Young, Inoperable and Regurgitant.  Heart Lung Circ. 2016 Oct;25(10):e126-9. Rank 113/194 | Impact Factor 2.2

  89. Rajwani A, Nelson AJ, Shirazi MG, Disney PJ, Teo KS, Wong DT, Young GD, Worthley SG. CT sizing for left atrial appendage closure is associated with favourable outcomes for procedural safety.  Eur Heart J Cardiovasc Imaging. 2016 Dec 24. Rank 35/194 | Impact Factor 4.8

  90. Nelson AJ, Montarello NJ, Roberts-Thomson RL, Montarello N, Delacroix S, Chokka R, Thomas T, Worthley SG.   Fungal obstruction of Transcatheter Aortic Valve Replacement valve.  Circ Cardiovasc Interv. 2016 Aug;9(8). Rank 27/194 | Impact Factor 5.5

  91. Nelson AJ, Worthley MI. Dual antiplatelet therapy: a moving target.  Medicine Today 2016; 17(7): 53-56. Impact Factor 0.5

  92. Wong GR, Scherer DJ, Nelson AJ, Worthley MI.  Non-traumatic spinal intradural haematoma: a rare case of paralysis following abciximab for ST elevation acute coronary syndrome.  BMJ Case Rep. 2016 May 10;2016. Impact Factor 0.4

  93. Delacroix S, Chokka RG, Nelson AJ, Nicholls SJ, Worthley SG.  Renal Denervation: An Update.  Journal of Advanced Therapies and Medical Innovation Sciences 2016;1:5-8.

  94. Montarello NJ, Nelson AJ, Sidharta SL, Worthley SG.  Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Basilar Artery Ischemic Stroke Following Transfemoral Transcatheter Aortic Valve Implantation. J Heart Valve Dis. 2016 Jan;25(1):14-17. Impact Factor 0.5

  95. Wong GR, Roberts-Thomson RL, Parvar SL, Nelson AJ.  Large Apical Thrombus due to Takotsubo Cardiomyopathy.  BMJ Case Rep. 2016 Feb 15;2016. Impact Factor 0.4

  96. Nelson AJ, Wong GR, Roberts-Thomson RL, Parvar SL. Massive pulmonary embolism with acute cor pulmonale.  Postgrad Med J. 2016 Aug;92(1090):487-8. Rank 76/168 | Impact Factor 1.9

  97. Wong GR, Nelson AJ, Rajwani A. Cor Medusae: Giant Coronary Arteriovenous Fistula.  Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):976-977 Rank 37/168 | Impact Factor 4.6

  98. Wong GR, Roberts-Thomson RL, Nelson AJ. Defibrillator Lead Endocarditis.  Eur Heart J Cardiovasc Imaging. 2015 Dec;16(12):1407. Rank 35/194 | Impact Factor 4.8

  99. Dundon BK, Pisaniello AD, Nelson AJ, Maia M, Teo KSL, Worthley SG, Coates PT, Russ GR, Faull RJ, Bannister K, Worthley MI.  Dobutamine Stress Cardiac MRI for Assessment of Coronary Artery Disease Prior to Kidney Transplantation. Am J Kidney Dis. 2015 May;65(5):808-9. Rank 8/85 | Impact Factor 6.6

  100. Abed H, Nelson AJ, Richardson JD, Worthley SG, Vincent A, Wittert GA, Leong DP.  Impact of Weight Reduction on Pericardial Adipose Tissue and Cardiac Structure in Patients with Atrial Fibrillation.  Am Heart J. 2015 May;169(5):655-662. Rank 47/194 | Impact Factor 4.2

  101. Puri R, Nicholls SJ, Brennan DM, Andrews J, Liew GY, Carbone A, Copus B, Nelson AJ, Kapadia SR, Tuzcu EM, Beltrame JF, Worthley SG, Worthley MI.  Coronary atheroma composition and its association with segmental endothelial dysfunction in non-ST segment elevation myocardial infarction: novel insights with radiofrequency (iMAP) intravascular ultrasonography.  Int J Cardiovasc Imaging. 2015 Feb;31(2):247-57. Rank 125/194 | Impact Factor 2.0

  102. Shah A, Wong DTL, Richardson JD, Li A, Nelson AJ, Shirazi M, Bradley J, Teo KS, Worthley MI and Worthley SG. Evaluation of Mitral Inflow Velocity Profile: Optimal Through Plane Location for Mitral Inflow Assessment with Cardiac Magnetic Resonance.  Exp Clin Cardiol 2014:20(1);975-1001.

  103. Dundon BK, Torpey DK, Nelson AJ, Wong DTL, Duncan RF, Meredith IT, Faull RJ, Worthley SG, Worthley MI.  Beneficial Cardiovascular Remodelling Following Arterio-Venous Fistula Ligation Post-Renal transplantation: A Longitudinal Magnetic Resonance Imaging Study. Clin Transplant. 2014 Aug;28(8): 916-25. Rank 16/24 | Impact Factor 1.7.

  104. Dundon BK, Torpey DK, Nelson AJ, Wong DTL, Duncan RF, Meredith IT, Faull RJ, Worthley SG, Worthley MI.  The Deleterious Effects of Arteriovenous Fistula Creation on the Cardiovascular System: A Longitudinal Magnetic Resonance Imaging Study.  Int J Nephrol Renovasc Dis. 2014 Sep 16;7:337-45. Impact Factor 2.4

  105. Sidharta S, Puri R, Frost L, Kataoka Y, Carbone A, Willoughby SR, Nelson A, Nicholls SJ, Worthley SG, Worthley MI.  The Impact of Lumen Size and Microvascular Resistance on Fourier-Domain Optical Coherence Tomography (FD-OCT) Coronary Measurements. Int J Cardiol. 2014 Jun 1;174(1):210-1. Rank 71/194 | Impact Factor 3.2

  106. Puri R, Nicholls SJ, Brennan DM, Andrews J, King KL, Liew GY, Carbone A, Copus B, Nelson AJ, Kapadia SR, Tuzcu EM, Beltrame JF, Worthley SG, Worthley MI. Left Main Coronary Arterial Endothelial Function and Heterogenous Segmental Epicardial Vasomotor Reactivity In Vivo: Novel Insights With Intravascular Ultrasonography. Eur Heart J Cardiovasc Imaging. 2014 Nov;15(11):1270-80. Rank 35/194 | Impact Factor 4.8

  107. Sidharta S, Sajeev J, Nelson AJ, Cooke J, Worthley MI.  Stress-induced cardiomyopathy: a review of the literature and possible link to cerebral executive function. Prim Care Companion CNS Disord. 2013;15(6). Impact Factor 1.2

  108. Willoughby SR, Luu LJ, Cameron JD, Nelson AJ, Schultz CD, Worthley SG, Worthley MI. Clopidogrel improves Microvascular Endothelial Function in Subjects with Stable Coronary Artery Disease.  Heart Lung Circ. 2014 Jun;23(6):534-41. Rank 113/194 | Impact Factor 2.2

  109. Dawood US, Nelson AJ, Wu D, Russ G. Disseminated adenovirus infection in kidney transplant recipient. Nephrology. 2014:19:10-13. doi: 10.1111/nep.12192. Impact Factor 1.7

  110. Richardson JD, Psaltis PJ, Frost L, Paton S, Carbone A, Bertaso AG, Nelson AJ, Wong DT, Worthley MI, Gronthos S, Zannettino AC, Worthley SG.  Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction. Cytotherapy. 2014 Apr;16(4):460-70. Impact Factor 4.3

  111. Puri R, Leong DP, Nicholls SJ, Liew GYL, Nelson AJ, Carbone AC, Copus B, Wong DT, Beltrame JP, Worthley SG, Worthley MI. Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodeling in patients with coronary artery disease. EuroIntervention. 2015 Apr;10(12):1440-8. Rank 53/194 | Impact Factor 4.0

  112. Puri R, Nicholls SJ, Nissen SE, Brennan DM, Andrews J, Liew GY, Nelson AJ, Carbone A, Copus B, Tuzcu EM, Beltrame JF, Worthley SG, Worthley MI. Coronary endothelium-dependent vasoreactivity and atheroma volume in subjects with stable, minimal angiographic disease versus non-ST-segment-elevation myocardial infarction: an intravascular ultrasound study. Circ Cardiovasc Imaging. 2013 Sep;6(5):674-82. Rank 25/194 | Impact Factor 5.7

  113. Richardson JD, Bertaso AG, Frost L, Wong DTL, Nelson AJ, Carbone A, Zannettino ACW, Gronthos S, Worthley MI.  Cardiac Magnetic Resonance, Transthoracic and Transoesophageal Echocardiography; A Comparison of in-vivo Assessment of Ventricular Function in Rats. Lab Anim. 2013 Oct;47(4):291-300. Impact Factor 2.2

  114. Richardson JD, Bertaso AG, Psaltis PJ, Frost L, Carbone A, Paton S, Nelson AJ, Wong DTL, Worthley MI,  Gronthos S, Zannettino ACW, Worthley SG.  Impact of Timing and Dose of Mesenchymal Stem Cell Therapy in a Preclinical Model of Acute Myocardial Infarction.  J Card Fail. 2013 May;19(5):342-53. Rank 65/194 | Impact Factor 3.6

  115. Nelson AJ, Nelson SV, Linn A, Raw L, Kildea HB, Tonkin A.  Tomorrow’s teachers…today?  Implementation of near-peer teaching.  Med Teach. 2013;35(2):156-9. Impact Factor 2.6

  116. Nelson AJ, Puri R, Psaltis PJ, Sanders P, Young GD.  Lead-preserving strategies for pacemaker pocket infection: who, when and how?  Indian Pacing Electrophysiol J. 2012 Nov;12(6):294-6. Impact Factor 0.4

  117. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, Mahajan R, Kuklik P, Zhang Y, Brooks AG, Nelson AJ, Worthley SG, Abhayaratna WP, Kalman JM, Wittert GA, Sanders P.  Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation.  Heart Rhythm. 2013 Jan;10(1):90-100. Rank 24/194 | Impact Factor 5.7

  118. Martinello M, Nelson A, Bignold L, Shaw D.  ‘We are what we eat!’ Invasive Intestinal Mucormycosis: a case report and review of the literature.  Med Mycol Case Rep. 2012 1(1);52-55. Impact Factor 1.5

  119. Bertaso AG, Richardson JD, Wong DTL, Nelson AJ, Tayeb H, Williams K, Worthley MI, Teo KSL, Worthley SG.  Prognostic value of adenosine stress perfusion cardiac MRI in an intermediate cardiovascular risk population. Int J Cardiol. 2013 Sep 1;167(5):2055-60. Rank 71/194 | Impact Factor 3.2

  120. Richardson JD, Cunnington M, Nelson AJ, Bradley JA, Teo KS, Worthley SG, Worthley MI.  Like a House Afire: Cardiac Sarcoidosis. Am J Med. 2013 Jan;126(1):21-4. Rank 23/1684 | Impact Factor 4.5

  121. Carbone A, Psaltis PJ, Nelson AJ, Weightman M, Thomas T, Williams K, Metcalf R, Young G, Worthley SG.  Dietary Omega-3 supplementation fails to protect against anthracycline-induced cardiotoxicity in a preclinical model.  J Card Fail. 2012 Jun;18(6):502-1. Rank 65/194 | Impact Factor 3.6

  122. Richardson JD, Nelson AJ, Worthley SG, Gronthos S, Zannetino A, Psaltis PJ. Optimisation of the Cardiovascular Therapeutic Properties of Mesenchymal Stromal Cells  – Taking The Next step.  Stem Cell Rev. 2013 Jun;9(3):281-302. Impact Factor 5.3

  123. Wong DTL, Richardson JD, Puri R, Nelson AJ, Bertaso AG, Teo KSL, Worthley MI, Worthley SG.  The Role of Cardiac Magnetic Resonance Imaging Following Acute Myocardial Infarction.  Eur Radiol. 2012 Aug;22(8):1757-68. Impact Factor 4.1

  124. Viswanathan G, Kidambi A, Nelson A, Mayurathan G, Hardy J, Kestevan P, Zaman A.  Glycoprotein IIb/IIIa Inhibitor Associated Severe Thrombocytopenia in Patients with Coronary Artery Disease: Clinical Course and Outcomes. Platelets. 2012;23(3):224-8. Impact Factor 3.3

  125. Puri R, Liew GYH, Nicholls SJ, Nelson AJ, Leong DP, Carbone A, Copus B, Wong DTL, Beltrame JF, Worthley SG, Worthley MI.  Salbutamol, Coronary Endothelial Function and Segmental Plaque Burden: Novel Mechanistic Insights From an in vivo Intravascular Ultrasound Study in Humans. Eur Heart J. 2012 Feb;33(4):495-504. Rank 2/194 | Impact Factor 22.7

  126. Richardson JD, Nelson AJ, Worthley SG, Teo K, Baillie T, Worthley MI.  Multivessel coronary artery spasm. Heart Lung Circ. 2012 Feb;21(2):113-6. Rank 113/194 | Impact Factor 2.2

  127. Puri R, Nelson AJ, Liew GY, Nicholls SJ, Carbone A, Wong DT, Harvey JE, Uno K, Copus B, Leong DP, Beltrame JF, Worthley SG, Worthley MI. Variations in human coronary lumen dimensions measured in vivo.  JACC Cardiovasc Imaging. 2012 Jan;5(1):123-4. Rank 7/194 | Impact Factor 12.7

  128. Puri R, Psaltis PJ, Nelson AJ, Sanders P, Young G.  Povidone-Iodine Irrigation – A Possible Alternative to Lead Extraction.  Indian Pacing Electrophysiol J. 2011 Jul;11(4):115-9. Impact Factor 0.4

  129. Duncan RF, Dundon BK, Nelson AJ, Pemberton J, Williams K, Worthley MI, Zaman A, Thomas H, Worthley SG. The 17-segment A study of the 16-Segment Regional Wall Motion Scoring Index and biplane Simpson’s rule for the calculation of left ventricular ejection fraction: a comparison with cardiac magnetic resonance imaging.  Echocardiography. 2011 Jul;28(6):597-604. Rank 161/194 | Impact Factor 1.4

  130. Nelson AJ, Worthley MI, Cameron JD.  Regional differences in aortic geometry pathologic or compensatory? JACC Cardiovasc Imaging. 2011 May;4(5):562-3. Rank 7/194 | Impact Factor 12.7

  131. Lau DH, Psaltis PJ, Carbone A, Kelly DJ, Mackenzie L, Worthington M, Metcalf RG, Kuklik P, Nelson AJ, Zhang Y, Wong CX, Brooks AG, Saint DA, James MJ, Edwards J, Young GD, Worthley SG, Sanders P.  Atrial Protective Effects Of N-3 Polyunsaturated Fatty Acids: A Long Term Study In Ovine Chronic Heart Failure. Heart Rhythm. 2011 Apr;8(4):575-82. Rank 24/194 | Impact Factor 5.7

  132. Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Leong DP, Lau DH, Roberts-Thomson KC, Wittert GA, Abhayaratna W, Worthley SG, Sanders P.  Pericardial Fat Is Associated with Atrial Fibrillation Severity And Ablation Outcome. J Am. Coll. Cardiol. 2011 Apr 26;57(17):1745-51. Rank 3/194 | Impact Factor 20.6

  133. Tayeb H, Nelson AJ, Willoughby SR, Worthley MI.   Antiplatelet Therapy in Acute Coronary Syndromes: Current Agents and Impact on Patient Outcomes.  Patient Relat. Outcome Meas. 2011 Jul;2:7-19

  134. Lau DH, Psaltis PJ, Mackenzie L, Kelly DJ, Carbone A, Nelson AJ, Worthington M, Zhang Y, Kuklik P, Wong CX, Edwards J, Saint DA, Worthley SG, Sanders P.  Atrial Remodelling in an Ovine Model of Anthracycline-Induced Non-Ischaemic Cardiomyopathy: remodelling of the same sort. J Cardiovasc Electrophysiol. 2011 Feb;22(2):175-82. Rank 100/194 | Impact Factor 2.4

  135. Psaltis PJ, Carbone A, Leong DP, Lau DH, Nelson AJ, Jantzen T, Manavis J, Williams K, Sanders P, Gronthos S, Zannettino ACW, Worthley SG.  Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy. Int J Cardiovasc Imaging. 2011 Jan;27(1):25-37. Rank 125/194 | Impact Factor 2.0

  136. Wong CX, Nelson AJ, Roberts-Thomson RL.  National approaches for medical school entry. Med J Aust. 2010; 193 (7): 428. Rank 16/168 | Impact Factor 6.1

  137. Psaltis PJ, Carbone A, Nelson AJ, Lau DH, Jantzen T, Manavis J, Williams K, Itescu S, Sanders P, Gronthos S, Zannettino ACW, Worthley SG. Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy. JACC Cardiovasc Interv. 2010;3(9):974-8. Rank 12/194 | Impact Factor 8.4

  138. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Brooks AG, Worthington M, Rajendram A, Kelly DR, Zhang Y, Kuklik P, Nelson AJ, Wong CX, Worthley SG, Rao M, Faull RJ, Edwards J, Saint DA, Sanders P. Hypertension and atrial fibrillation: Evidence of progressive atrial remodeling with electro-structural correlate in a conscious chronically instrumented ovine model. Heart Rhythm 2010; 7:1282-1290. Rank 24/194 | Impact Factor 5.7

  139. Lau DH, Mackenzie L, Kelly DJ, Worthington M, Psaltis PJ, Rajendram A, Nelson AJ, Kelly DR, Zhang Y, Worthley SG, Faull RJ, Rao M, Edwards J, Saint DA, Sanders P.  Short term hypertension is associated with the development of the substrate for atrial fibrillation:  A study in an ovine hypertensive model. Heart Rhythm. 2010;7(3):396-404. Rank 24/194 | Impact Factor 5.7

  140. Wong CX, Wong MX, Wong NX, Sun MT, Brooks AG, Stiles MK, Lau DH, Nelson AJ, De Sciscio P, Shipp NJ, Sanders P. Impact of Research Presentations at the Annual Scientific Sessions of the Heart Rhythm Society. Heart Rhythm 2009; 6(9):1345-1348. Rank 24/194 | Impact Factor 5.7

  141. Wittert GA, Nelson AJ. Medical Education: Revolution, Devolution and Evolution in Curriculum Philosophy and Design. Med J Aust. 2009 Jul 6;191(1):35-7. Rank 16/168 | Impact Factor 6.1

  142. Nelson AJ, Worthley MI, Psaltis PJ, Carbone A, Dundon BK, Lau DH, Duncan RF, Piantadosi C, Sanders P, Wittert GA, Worthley SG.  Validation of Cardiovascular Magnetic Resonance assessment of Pericardial Adipose Tissue Volumes. J Cardiovasc Magn Reson. 2009 May 5;11(1):15. Rank 28/194 | Impact Factor 5.3

  143. Nelson AJ, Worthley SG, Cameron JD, Willoughby SR, Piantadosi C, Carbone A, Dundon BK, Leung MC, Hope SA, Meredith IT, Worthley MI.  Cardiovascular magnetic resonance derived aortic distensibilty:  validation and observed regional differences in the elderly. J Hypertens. 2009 Mar;27(3):535-42. Rank 45/194 | Impact Factor 4.2

  144. Psaltis PJ, Carbone A, Nelson AJ, Lau DH, Manavis J, Finnie J, Teo KSL, McKenzie L, Sanders P, Gronthos S, Zannettino ACW, Worthley SG.  An ovine model of toxic, non-ischemic cardiomyopathy – assessment by cardiac magnetic resonance imaging. J Card. Fail. 2008 Aug;14(9);785-795. Rank 65/194 | Impact Factor 3.6

   

• Professional Associations

  2022- National Association of Clinical Obesity Services (NACOS), Member

  2022- National Lipid Association, Member

  2022- Australian Atherosclerosis Society, Member

  2021- Australian Clinical Trials Alliance, Member

  2021- Society of Cardiovascular Computed Tomography, Fellow Member

  2020- American Society of Preventive Cardiology, Fellow Member

  2020- Asia-Pacific CardioMetabolic Consortium, Founding Member

  2020- Asia-Pacific Society of Preventive Cardiology, Fellow Member

  2020- Society for Cardiovascular Angiography and Interventions, Fellow Member

  2018- American College of Cardiology, Fellow Member

  2018- European Society of Cardiology, Fellow Member

  2018- American Heart Association, Associate Member

  2017- Royal Australian College of Physicians, Fellow

  2015- Cardiac Society of Australia and New Zealand, Member

  2011- Australian Medical Association (SA), Member

Entry last updated: Saturday, 4 Mar 2023

To link to this page, please use the following URL:  https://www.adelaide.edu.au/directory/adam.nelson